tiprankstipranks
Trending News
More News >
Philip Morris International (PM)
:PM
Advertisement

Philip Morris (PM) AI Stock Analysis

Compare
7,186 Followers

Top Page

PM

Philip Morris

(NYSE:PM)

Rating:68Neutral
Price Target:
$182.00
▲(10.88% Upside)
Philip Morris's strong earnings call and solid financial performance are the primary drivers of its stock score. However, high leverage and negative equity on the balance sheet, along with bearish technical indicators, pose risks. The high P/E ratio suggests potential overvaluation, but the attractive dividend yield provides some offset.
Positive Factors
Growth Potential
PM has the highest long-term growth profile among mega-cap CPG peers, but is trading at a ~27% discount to theoretical fair value.
Market Overreaction
The -8% sell-off of PM presents an attractive buying opportunity, with high expectations into the print and the market over-reacting to short-term Zyn phasing headwinds.
Product Innovation
High volume, high margin smoke-free products are seen as warranting a premium multiple.
Negative Factors
Revenue Performance
A revenue miss and softer than expected U.S. Zyn shipments failed to exceed a very high bar and the shares were punished as a result.
Sales Performance
PM's stock fell 8% as its US ZYN volumes in 2Q were shy of market expectations.

Philip Morris (PM) vs. SPDR S&P 500 ETF (SPY)

Philip Morris Business Overview & Revenue Model

Company DescriptionPhilip Morris International Inc. (PM) is a leading global tobacco company engaged in the manufacture and sale of cigarettes, smoke-free products, and related devices and accessories. With a significant international presence, PM aims to transition adult smokers to less harmful alternatives through its innovative smoke-free products, including heated tobacco and nicotine-containing vapor products. The company's flagship brand, Marlboro, is one of the most recognized and best-selling cigarette brands worldwide.
How the Company Makes MoneyPhilip Morris International generates revenue primarily through the sale of its tobacco products, including cigarettes and smoke-free alternatives. The company's revenue streams are largely driven by its portfolio of popular brands, with Marlboro being a significant contributor. PM has been investing in the development and commercialization of reduced-risk products, such as its IQOS platform, which heats rather than burns tobacco, offering a potentially less harmful alternative to traditional smoking. The company leverages its extensive distribution network and strategic partnerships to expand its market reach and enhance sales. Additionally, PM benefits from pricing power in various markets, allowing it to maintain profitability even as global cigarette consumption declines. The company is also focused on expanding its presence in emerging markets where smoking rates remain high, thereby bolstering its revenue potential.

Philip Morris Key Performance Indicators (KPIs)

Any
Any
Shipment Volume by Product Type
Shipment Volume by Product Type
Monitors the quantity of products shipped across different categories, providing insight into consumer demand trends and product popularity.
Chart InsightsPhilip Morris is experiencing a strategic shift with a notable increase in heated tobacco and oral product shipments, while cigarette volumes show a gradual decline. The earnings call highlights a robust performance in the smoke-free segment, with a 14.4% rise in shipment volumes, indicating a successful pivot towards reduced-risk products. The ZYN product line's impressive growth further underscores this transition. Despite challenges like geographic mix and currency volatility, the company's focus on smoke-free products is driving significant revenue and profit growth, aligning with its long-term strategic goals.
Data provided by:Main Street Data

Philip Morris Earnings Call Summary

Earnings Call Date:Jul 22, 2025
(Q2-2025)
|
% Change Since: -9.05%|
Next Earnings Date:Oct 21, 2025
Earnings Call Sentiment Positive
The earnings call for Philip Morris International was generally positive, highlighting strong growth in smoke-free products, particularly IQOS and ZYN, and improved profitability metrics. However, challenges remain with declining cigarette volumes and regulatory uncertainties in Europe. Currency impacts have also slightly dampened financial outcomes.
Q2-2025 Updates
Positive Updates
Strong Smoke-Free Product Growth
Philip Morris reported $4 billion in net revenues from their smoke-free portfolio, with double-digit adjusted diluted EPS growth in both constant currency and dollar terms. IQOS, ZYN, and VEEV showed strong performance, with IQOS in-market sales growth accelerating to 11.4% in Q2 and 26% US consumer offtake growth in Q2.
Increased Revenue and Earnings
The company achieved over $10 billion in quarterly net revenues for the first time, with organic net revenues growing by more than 8% excluding the Indonesia impact. Adjusted operating income grew by 14.9% organically, with a 20% increase in adjusted diluted EPS.
ZYN's Strong Performance in the US
ZYN's US offtake growth reaccelerated to 36% in June after resolving supply constraints, marking a return to its category-driving position. The company plans to continue its growth trajectory with increased production capacity.
Margin Expansion
There was a 300 basis points organic gross margin expansion in H1, driven by smoke-free growth contributing 190 basis points. This reflects significant profitability increases in smoke-free categories.
Positive Outlook and Updated Guidance
Philip Morris raised their adjusted diluted EPS forecast for the full year to 13% to 15% growth in dollar terms, reflecting strong smoke-free product momentum and improved tax rates.
Negative Updates
Combustible Volume Decline
Cigarette volumes declined modestly in Q2, with a forecasted decline of around 2% for the year. This includes challenges in Turkey and Indonesia, where supply chain issues and a growing illicit segment are impacting volumes.
Regulatory Challenges
The EU tobacco excise directive proposal lacks plans to counter illicit trade, which accounted for 9.2% of total EU cigarette consumption in 2024, leading to significant tax revenue loss.
Currency Impact
The impact of currency volatility, particularly with the Swiss franc, led to a transactional loss, affecting the company’s earnings despite a favorable dollar environment.
Company Guidance
During the Philip Morris International 2025 second quarter results conference call, the company reported strong financial performance, highlighting a $4 billion net revenue from smoke-free products and a significant double-digit growth in adjusted diluted earnings per share. The IQOS brand showed an 11.4% growth in heated tobacco unit sales, with a notable acceleration in offtake growth in the U.S. and international nicotine pouch volumes increasing by 65%. Despite a minor decline in combustible volumes, the company achieved robust top and bottom-line performance, driven by strong pricing and cost efficiencies. Philip Morris raised its full-year adjusted diluted EPS forecast to 13-15% growth, even as it anticipated some challenges in the second half due to timing factors and combustible volume dynamics. The company remains confident in its smoke-free momentum and aims for continued growth with a strong cash flow forecast of $11.5 billion.

Philip Morris Financial Statement Overview

Summary
Philip Morris shows strong revenue growth and profitability margins with a robust income statement. However, high leverage and negative equity on the balance sheet pose significant financial risks. Cash flow generation is efficient, although there's a slight decline in growth.
Income Statement
85
Very Positive
Philip Morris has demonstrated strong revenue growth with a TTM revenue of $39.01 billion, representing a 2.96% increase from the previous year. The gross profit margin is robust at 65.78%, alongside a healthy EBIT margin of 37.02% and EBITDA margin of 42.07%. However, the net profit margin slightly decreased to 21.06% from 18.57% a year ago, indicating some pressure on net profitability.
Balance Sheet
60
Neutral
The balance sheet reflects high leverage with a negative stockholders' equity of -$11.97 billion, resulting in an unfavorable debt-to-equity ratio. The equity ratio is negative, highlighting financial instability. Despite this, the return on equity (ROE) is not applicable due to negative equity, posing a risk to financial health.
Cash Flow
78
Positive
Philip Morris's operating cash flow remains robust at $10.41 billion TTM, with a decrease from the previous year. Nevertheless, FCF remains strong at $8.99 billion, with the free cash flow to net income ratio at 1.09. The operating cash flow to net income ratio is healthy at 1.27, suggesting efficient cash generation with some indication of declining growth.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue37.88B35.17B31.76B31.41B28.69B
Gross Profit24.55B22.28B20.36B21.38B19.13B
EBITDA15.75B13.37B13.48B13.97B12.66B
Net Income7.03B7.79B9.05B9.11B8.06B
Balance Sheet
Total Assets61.78B65.30B61.68B41.29B44.81B
Cash, Cash Equivalents and Short-Term Investments4.22B3.06B3.21B4.50B7.28B
Total Debt45.70B47.91B43.12B27.81B31.54B
Total Liabilities71.65B74.75B67.99B49.50B55.45B
Stockholders Equity-11.75B-11.22B-8.96B-10.11B-12.57B
Cash Flow
Free Cash Flow10.77B7.88B9.73B11.22B9.21B
Operating Cash Flow12.22B9.20B10.80B11.97B9.81B
Investing Cash Flow-1.09B-3.60B-15.68B-2.36B-1.15B
Financing Cash Flow-9.48B-5.58B3.81B-11.98B-8.50B

Philip Morris Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price164.14
Price Trends
50DMA
176.24
Negative
100DMA
168.48
Negative
200DMA
149.13
Positive
Market Momentum
MACD
-4.33
Positive
RSI
39.41
Neutral
STOCH
59.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PM, the sentiment is Neutral. The current price of 164.14 is below the 20-day moving average (MA) of 170.55, below the 50-day MA of 176.24, and above the 200-day MA of 149.13, indicating a neutral trend. The MACD of -4.33 indicates Positive momentum. The RSI at 39.41 is Neutral, neither overbought nor oversold. The STOCH value of 59.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PM.

Philip Morris Risk Analysis

Philip Morris disclosed 33 risk factors in its most recent earnings report. Philip Morris reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Philip Morris Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$2.72B30.904.07%0.36%75.72%-6.45%
71
Outperform
$105.03B11.97-503.31%6.60%-0.18%-10.69%
70
Neutral
$1.45B35.8326.05%0.36%4.44%-5.94%
68
Neutral
$0.0030.93-37142.11%3.29%7.44%-6.72%
63
Neutral
$20.31B12.53-7.33%3.14%2.97%-12.13%
63
Neutral
$1.34B14.126.56%6.02%7.23%-20.91%
62
Neutral
$122.52B30.915.97%5.34%0.48%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PM
Philip Morris
164.14
52.77
47.38%
MO
Altria Group
62.52
16.05
34.54%
BTI
British American Tobacco
55.84
22.94
69.73%
UVV
Universal
53.99
7.27
15.56%
TPB
Turning Point Brands
81.14
43.92
118.00%
RLX
RLX Technology
2.23
0.67
42.95%

Philip Morris Corporate Events

Business Operations and StrategyFinancial Disclosures
Philip Morris Highlights Smoke-Free Strategy in Europe
Positive
Jun 24, 2025

On June 24, 2025, Philip Morris International hosted the Europe Investor Focus Event, presenting its strategic focus on smoke-free products and the company’s performance in the European market. The event highlighted PMI’s strong market position, with significant contributions to the EU economy and impressive growth in smoke-free product revenues, despite facing various business risks and regulatory challenges.

The most recent analyst rating on (PM) stock is a Buy with a $110.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

DividendsBusiness Operations and Strategy
Philip Morris Declares Quarterly Dividend Amid Smoke-Free Transition
Positive
Jun 13, 2025

On June 13, 2025, Philip Morris International’s Board of Directors declared a regular quarterly dividend of $1.35 per common share, payable on July 15, 2025. This announcement reflects PMI’s ongoing commitment to shareholder returns while it continues to transition towards a smoke-free future. The company’s strategic focus on smoke-free products and its significant investments in this area underscore its ambition to expand into wellness and healthcare, potentially enhancing its industry positioning and stakeholder value.

The most recent analyst rating on (PM) stock is a Buy with a $110.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
Philip Morris Issues €1 Billion in Notes
Neutral
Jun 6, 2025

On June 6, 2025, PMI issued €1 billion in aggregate principal amount of Notes, divided equally between 2.750% Notes due 2029 and 3.250% Notes due 2032. The proceeds from this issuance are intended for general corporate purposes, including repaying outstanding commercial paper and meeting working capital requirements. The Notes, which are senior unsecured obligations, are subject to covenants and redemption options, and interest payments will begin in 2026. This financial maneuver is part of PMI’s broader strategy to manage its debt and financial operations effectively, impacting its market positioning and stakeholder relations.

The most recent analyst rating on (PM) stock is a Buy with a $175.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
Philip Morris Reaffirms 2025 Financial Forecast at Conference
Positive
Jun 3, 2025

On June 3, 2025, Philip Morris International’s CFO, Emmanuel Babeau, participated in the Deutsche Bank Global Consumer Conference, reaffirming the company’s full-year forecast for 2025. PMI projects a reported diluted EPS of $7.01 to $7.14 and an adjusted diluted EPS of $7.36 to $7.49, indicating a growth of 12% to 14%, or 10.5% to 12.5% excluding currency effects. This announcement underscores PMI’s strategic focus on transitioning towards smoke-free products and its commitment to financial growth, which is significant for investors and stakeholders.

The most recent analyst rating on (PM) stock is a Buy with a $110.00 price target. To see the full list of analyst forecasts on Philip Morris stock, see the PM Stock Forecast page.

Shareholder Meetings
Philip Morris Holds Annual Shareholder Meeting
Neutral
May 9, 2025

On May 7, 2025, Philip Morris International Inc. held its Annual Meeting of Shareholders, where a quorum of 1,269,535,339 shares was represented. All director nominees were elected, executive compensation was approved on an advisory basis, and PricewaterhouseCoopers SA was ratified as the independent auditor for the fiscal year ending December 31, 2025.

Executive/Board ChangesShareholder MeetingsBusiness Operations and StrategyFinancial Disclosures
Philip Morris Holds 2025 Virtual Annual Meeting
Positive
May 7, 2025

On May 7, 2025, Philip Morris International Inc. held its 2025 Virtual Annual Meeting of Shareholders, where Chairman André Calantzopoulos and CEO Jacek Olczak discussed the company’s excellent performance in 2024 and a strong start to 2025. They highlighted PMI’s achievements in its smoke-free journey, including reaching $15 billion in net revenues from smoke-free products, and the company’s commitment to sustainable growth and shareholder returns. The meeting also saw the election of 11 directors and the approval of executive compensation and auditors. PMI continues to advance its multicategory strategy with leading brands like IQOS, ZYN, and VEEV, reinforcing its position as a global smoke-free champion.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 07, 2025